Effectiveness outcomes and health related quality of life impact of disease progression in patients with advanced nonsquamous NSCLC treated in real-world community oncology settings: results from a prospective medical record registry study

BACKGROUND: Treatment options for advanced nonsquamous non-small cell lung cancer (NSCLC) in the first line include platinum-based doublet therapy with or without bevacizumab. This study examined efficacy outcomes and patient reported outcomes (PROs) in a community oncology patient sample. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Mark S., Wong, William, Ravelo, Arliene, Miller, Paul J. E., Schwartzberg, Lee S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557319/
https://www.ncbi.nlm.nih.gov/pubmed/28806963
http://dx.doi.org/10.1186/s12955-017-0735-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557319/
https://www.ncbi.nlm.nih.gov/pubmed/28806963
http://dx.doi.org/10.1186/s12955-017-0735-4

Ejemplares similares